financetom
Business
financetom
/
Business
/
US chipmaker Intel appoints Lip-Bu Tan as its CEO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US chipmaker Intel appoints Lip-Bu Tan as its CEO
Mar 12, 2025 1:46 PM

(Reuters) - Struggling U.S. chipmaker Intel ( INTC ) on Wednesday named former board member Lip-Bu Tan as its CEO effective March 18, more than two months after the it ousted company veteran Pat Gelsinger.

Tan, a well-respected semiconductor industry veteran, has long been seen as a CEO contender. He was approached by Intel's ( INTC ) board in December, Reuters had reported, to gauge his interest in taking up the job.

Shares of the company rose 11% in extended trading.

(Reporting by Bhanvi Satija in Bengaluru; Editing by Arun Koyyur)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Airbnb Insider Sold Shares Worth $17,155,152, According to a Recent SEC Filing
Airbnb Insider Sold Shares Worth $17,155,152, According to a Recent SEC Filing
Jun 26, 2024
05:06 PM EDT, 06/26/2024 (MT Newswires) -- Brian Chesky, 10% Owner, Director, CEO and Chairman, on June 24, 2024, sold 115,385 shares in Airbnb ( ABNB ) for $17,155,152. Following the Form 4 filing with the SEC, Chesky has control over a total of 14,158,241 shares of the company, with 14,029,687 shares held directly and 128,554 controlled indirectly. SEC Filing:...
US FDA approves Verona Pharma's therapy for 'smoker's lungs'
US FDA approves Verona Pharma's therapy for 'smoker's lungs'
Jun 26, 2024
June 26 (Reuters) - The U.S. Food and Drug Administration has granted approval for a treatment from Verona Pharma for a chronic lung disease that commonly affects smokers, the U.K.-based company said on Wednesday. The U.S. FDA's assent for the therapy, to be sold under the brand Ohtuvayre, is the company's first and provides a new inhaled non-steroidal treatment for...
Altria seeks FDA marketing order for oral nicotine pouch products
Altria seeks FDA marketing order for oral nicotine pouch products
Jun 26, 2024
June 26 (Reuters) - Tobacco giant Altria ( MO ) said on Wednesday it had submitted Premarket Tobacco Product Applications (PMTAs) to the U.S. Food and Drug Administration for its on! Plus oral nicotine pouch products. The FDA had authorized four of Altria's ( MO ) menthol e-cigarette products last week for sale in the U.S., making them the first...
Levi Strauss Fiscal Q2 Earnings, Revenue Rise; Dividend Boosted; Shares Fall After Hours
Levi Strauss Fiscal Q2 Earnings, Revenue Rise; Dividend Boosted; Shares Fall After Hours
Jun 26, 2024
05:06 PM EDT, 06/26/2024 (MT Newswires) -- Levi Strauss (LEVI) reported fiscal Q2 adjusted earnings late Wednesday of $0.16 per diluted share, up from $0.04 a year earlier. Analysts polled by Capital IQ expected $0.11. Net revenue in the quarter ended May 26 rose to $1.44 billion from $1.34 billion a year earlier. Analysts surveyed by Capital IQ expected $1.45...
Copyright 2023-2026 - www.financetom.com All Rights Reserved